Biden: I Beat Big Pharma in Insulin Price Battle

Published on March 15, 2023

President Joe Biden emerges victorious in his battle against exorbitant drug prices, likened to a grand showdown with Goliath. Despite years of struggling against the mighty pharmaceutical industry, Biden has finally managed to rein in the soaring cost of insulin. This accomplishment serves as a rallying cry for his expected re-election campaign. Just like David wielding his slingshot, Biden’s persistence and determination have prevailed, forcing Big Pharma to take a step back. The impact of this victory extends beyond just lowering insulin prices; it opens the door for further scrutiny of drug pricing practices and raises hope for more accessible healthcare in the future. By successfully tackling a long-standing issue, the President solidifies his commitment to championing affordable medications for all Americans. To learn more about Biden’s triumph over Big Pharma, delve into the underlying research and understand the interplay of politics and the pharmaceutical industry.

President Joe Biden claimed victory Wednesday over America’s pharmaceutical giants in forcing a modest retreat on exorbitant drug prices — a theme likely to be a central plank in his expected reelection campaign.”After decades of trying to take on Big Pharma, we finally,…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>